Literature Review

Instability of INRs


 

Clinical question: Does an initial stable international normalized ratio (INR) predict long-term stability?

Background: Warfarin decreases stroke risk among patients with atrial fibrillation; however, it interacts with food and drugs and requires monitoring to achieve a therapeutic INR. It is unclear if patients on warfarin with an initial stable INR value remain stable over time. Additionally, it is controversial whether patients on warfarin with previously stable INRs should benefit from switching to a non–vitamin K oral anticoagulant.

Study design: Retrospective study.

Setting: Outpatient clinics.


Synopsis: Data were collected from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. Included in the study were patients taking warfarin at baseline with three or more INR values in the first 6 months and six or more INR values in the subsequent year. Stability was defined as 80% or more INRs in therapeutic range (2.0-3.0).

Only 26% of patients taking warfarin had a stable INR during the first 6 months, and only 34% continued to have a stable INR in the subsequent year.

Bottom line: Initial stable INR within the first 6 months among patients taking warfarin does not predict long-term INR stability in the subsequent year.

Citation: Pokorney SD, Simon DN, Thomas L, et al. Stability of international normalized ratios in patients taking long-term warfarin therapy. JAMA.2016;316(6):661-663

Dr. Florindez is an assistant professor at the University of Miami Miller School of Medicine and a hospitalist at University of Miami Hospital and Jackson Memorial Hospital.

Recommended Reading

Heart failure readmission metric not linked to care quality
The Hospitalist
Observational hospital stays for HF linked to worse outcomes
The Hospitalist
Long-Term Mortality in Nondiabetic Patients Favors Coronary Artery Bypass Over Intervention with Drug-Eluting Stents
The Hospitalist
Sarah Stella, MD, Has a Heart for Safety-Net Hospital Medicine
The Hospitalist
Prevalence of Iron Deficiency in Heart Failure Patients, Study Says
The Hospitalist
Long-Term Mortality Benefits With Coronary Artery Bypass Grafting for Ischemic Cardiomyopathy
The Hospitalist
Troponin Leak Portends Poorer Outcomes in Congestive Heart Disease Hospitalizations
The Hospitalist
Prior clopidogrel tied to more events in medically treated ACS patients
The Hospitalist
Higher Risk of Cataracts After Percutaneous Coronary Intervention
The Hospitalist
Nonischemic cardiomyopathy does not benefit from prophylactic ICDs
The Hospitalist
   Comments ()